hom3

The Frankfurt Institute of Clinical Cancer Research (IKF)

Your Visions Translated Into Groundbreaking Research

We are IKF

Institute of Clinical Cancer Research IKF at Northwest Hospital

We are a globally acting clinical research institution specializing in investigator-initiated and industry-academia collaborative clinical cancer research.

Founded by oncologists driven by a shared vision to make a global impact, our mission is to advance science-driven cancer research through collaboration between industry and academia.

By leveraging the strengths and expertise of both sectors we strive to conduct transformative research and provide answers to crucial clinical questions.

Facts And Figures About Our Activities Since 2018

0+

Patients In Trials

0

Trial Sites

0

Academic Groups

0

Clinical Trials

0

Phase III Trials

0

Patients In Trial Annually

Facts And Figures About Our Activities Since 2018

Patients In Trials
0 +
Trial Sites
0
Academic Groups
0
Clinical Trials
0
Phase III Trials
0

Patients In Trial Annually
0

Our Research

Our research activities have a clear objective: to conduct and facilitate excellent clinical cancer research at the international level in order to improve the treatment and quality of life of cancer patients.

Our Service

Through our Comprehensive Research Organization service (CRO), our work covers all areas of clinical cancer research at the highest level.

What Sets Us Apart

Our team of physicians, who have years of expertise and current knowledge in medical care, are specialized in the fields of hematology, oncology, surgical oncology, palliative medicine, supportive therapy, and human genetics. Our founders are oncologists, and this expertise is a hallmark of IKF.

With well-established networks of almost hundreds of medical institutions, the best experts in their respective fields for every disease type, and the largest academic study groups in Germany and Europe, IKF has a powerful network that sets us apart.

IKF provides well-established access to routine clinical oncology environments through long-term collaborations with university hospitals, other large hospitals, and private oncology practitioners.

Our interactive and comprehensive molecular profiling network, PLATON, provides a unique opportunity to screen a sufficient number of patients with distinct genetic alterations/mutations for biomarker-based clinical trials.

Read More